Smith & Nephew plc (SNN)

Market Cap	13.66B +24.7%
Revenue (ttm)	6.16B +6.1%
Net Income	625.00M +51.7%
EPS	0.72 +52.3%
Shares Out	849.76M
PE Ratio	21.86
Forward PE	14.37
Dividend	$0.75 (2.36%)
Ex-Dividend Date	Mar 27, 2026

Volume	1,597,493
Open	32.29
Previous Close	32.74
Day's Range	31.74 - 32.52
52-Week Range	26.33 - 38.79
Beta	0.74
Analysts	Hold
Price Target	36.25 (+13.57%)
Earnings Date	Mar 16, 2026

About SNN

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 16, 1999
• Employees: 16,988
• Stock Exchange: NYSE
• Ticker Symbol: SNN
• Website: https://www.smith-nephew.com

Financial Performance

In 2025, Smith & Nephew's revenue was $6.16 billion, an increase of 6.09% compared to the previous year's $5.81 billion. Earnings were $625.00 million, an increase of 51.70%.

Analyst Summary

According to 2 analysts, the average rating for SNN stock is "Hold." The 12-month stock price target is $36.25, which is an increase of 13.57% from the latest price.

Price Target

$36.25

(13.57% upside)

Analyst Consensus: Hold